Founder, Chairman & CEO

Co-founder, VP of Technology

Human Longevity partners with Alamar Biosciences to enhance longevity research

Human Longevity taps precision proteomics for early detection

Prolon Next Gen brings fasting science to the table

Human Longevity to Add Alamar's NULISAseq Proteomic Panels to Service Offering

Director, BioPharma Business Development

Alamar Biosciences is on a mission to transform the field of proteomics for the early detection of cancer and other diseases. The Director, BioPharma Business Development will lead strategic partnerships and commercial initiatives within large pharmaceutical companies and biotech, focusing on increasing adoption of Alamar’s proteomics platform.

Sign up with Google

Sign in with Google